BEAMSTART Logo

HomeNews

New RSV vaccine, treatment linked to dramatic fall in baby hospitalizations

Ars Technica LogoArs Technica1d ago

New RSV vaccine, treatment linked to dramatic fall in baby hospitalizations - Ars Technica

Quick Summary:

CDC study finds big declines in hospitalizations—and they may be underestimates.

The other new protection against RSV is a long-acting monoclonal antibody treatment, nirsevimab, which is given to babies under 8 months old as they enter or are born into their first RSV season and may not be protected by maternal antibodies.

Newborns—babies between 0 and 2 months—are the most at risk of being hospitalized with RSV.

More Pictures

New RSV vaccine, treatment linked to dramatic fall in baby hospitalizations - Ars Technica (Picture 1)

or

Article Details

Author / Journalist: Beth Mole

Category: Technology

Markets:

Topics:

Source Website Secure: Yes (HTTPS)

News Sentiment: Negative

Fact Checked: Legitimate

Article Type: News Report

Published On: 2025-05-08 @ 21:54:14 (1 days ago)

News Timezone: GMT -5:00

News Source URL: arstechnica.com

Language: English

Article Length: 213 words

Reading Time: 2 minutes read

Sentences: 30 lines

Sentence Length: 8 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Ars Technica

News ID: 28500452

View Article Analysis

About Ars Technica

Ars Technica Logo

Main Topics: Technology

Official Website: arstechnica.com

Update Frequency: 5 posts per day

Year Established: 1998

Headquarters: United States

News Last Updated: 9 hours ago

Coverage Areas: United States

Ownership: Independent Company

Publication Timezone: GMT -5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #32

Publisher Details

Frequently Asked Questions

How long will it take to read this news story?

The story "New RSV vaccine, treatment linked to dramatic fall in baby hospitalizations" has 213 words across 30 sentences, which will take approximately 1 - 2 minutes for the average person to read.

Which news outlet covered this story?

The story "New RSV vaccine, treatment linked to dramatic fall in baby hospitalizations" was covered 1 days ago by Ars Technica, a news publisher based in United States.

How trustworthy is 'Ars Technica' news outlet?

Ars Technica is a fully independent (privately-owned) news outlet established in 1998 that covers mostly technology news.

The outlet is headquartered in United States and publishes an average of 5 news stories per day.

It's most recent story was published 9 hours ago.

What do people currently think of this news story?

The sentiment for this story is currently Negative, indicating that people regard this as "bad news".

How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
  • News ID: #28500452
  • URL: https://chronographically.beamstart.com/news/new-rsv-vaccine-treatment-linked-17467438105883

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

Our Company

© Copyright 2025 BEAMSTART. All Rights Reserved.